You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nilotinib

Showing 226 - 250 of 252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dynamics of ABL Mutations in Imatinib Failed CML Patients

Unknown status
  • Chronic Myeloid Leukemia
  • Nilotinib
  • Seoul, Korea, Republic of
    Seoul St. Mary's Hospital
Jan 10, 2014

Chronic Myeloid Leukemia Trial in Seoul (Nilotinib, Imatinib)

Unknown status
  • Chronic Myeloid Leukemia
  • Nilotinib, Imatinib
  • Seoul, Korea, Republic of
    Seoul St. Mary's Hospital
Jan 10, 2014

Pulmonary Arterial Hypertension Treated With Nilotinib

Withdrawn
  • PAH
    • Cleveland, Ohio
      Cleveland Clinic
    Feb 3, 2014

    Leukemia, Myeloid, Chronic, BCR-ABL Positive Trial in Monterrey (Imatinib and Nilotinib)

    Completed
    • Leukemia, Myeloid, Chronic, BCR-ABL Positive
    • Imatinib and Nilotinib
    • Monterrey, Nuevo Leon, Mexico
      Servicio de Hematologia, Hospital Universitario "José E. Gonzale
    Jan 3, 2014

    Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Imatinib)

    Terminated
    Has Results
    • Gastrointestinal Stromal Tumors
    • Caba, Buenos Aires, Argentina
    • +31 more
    Feb 25, 2014

    Leukemia, Lymphocytic, Acute Trial in Houston (Methotrexate, Vincristine, PEG-l-asparaginase)

    Completed
    Has Results
    • Leukemia, Lymphocytic, Acute
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jun 9, 2015

    Healthy Trial in Pittsburgh (Nilotinib Hydrochloride, calcium carbonate)

    Completed
    • Healthy
    • Nilotinib Hydrochloride
    • calcium carbonate
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Cancer Institute / Clinical and Transla
    Dec 17, 2013

    Gastrointestinal Stromal Tumors Trial in Philadelphia (Nilotinib)

    Terminated
    Has Results
    • Gastrointestinal Stromal Tumors
    • Nilotinib
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Apr 15, 2013

    Gastrointestinal Stromal Tumors Trial in France, Italy, United States (Nilotinib, Imatinib)

    Completed
    • Gastrointestinal Stromal Tumors
    • Nilotinib, Imatinib
    • Boston, Massachusetts
    • +3 more
    May 9, 2013

    Pigmented Villonodular Synovitis Trial in Worldwide (Tasigna)

    Completed
    • Pigmented Villonodular Synovitis
    • Bordeaux, France
    • +14 more
    Apr 15, 2013

    Philadelphia Chromosome Positive (Ph+) Leukemias, Chronic Myeloid Leukemia Trial in Portland (Ponatinib)

    No longer available
    • Philadelphia Chromosome Positive (Ph+) Leukemias
    • Chronic Myeloid Leukemia
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Mar 13, 2013

    Chronic Myeloid Leukemia Trial in United States (DCC-2036)

    Completed
    • Chronic Myeloid Leukemia
    • Duarte, California
    • +9 more
    Jul 16, 2014

    Acute Myeloid Leukemia Trial in Munich (NILOTINIB, EVEROLIMUS)

    Completed
    • Acute Myeloid Leukemia
    • Munich, Bavaria, Germany
      Medical faculty of the Technical University Munich
    Aug 7, 2012

    Gastrointestinal Cancer Trial (Nilotinib)

    Withdrawn
    • Gastrointestinal Cancer
    • Nilotinib
    • (no location specified)
    Aug 1, 2012

    Chronic Myeloid Leukemia Trial in Guadalajara, Jalisco, Mexico City (Nilotinib)

    Approved for marketing
    • Chronic Myeloid Leukemia
    • Nilotinib
    • Guadalajara, Jalisco, Mexico
    • +1 more
    Jul 17, 2012

    CML Trial in Petah tikva (Treatment modification based on molecular response at 3 months)

    Unknown status
    • CML
    • Treatment modification based on molecular response at 3 months
    • Petah tikva, Israel
      Rabin Medical Center
    Jan 7, 2013

    Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Best Supportive Care (BSC) +/- imatinib or sunitinib)

    Completed
    Has Results
    • Gastrointestinal Stromal Tumors
    • Nilotinib
    • Best Supportive Care (BSC) +/- imatinib or sunitinib
    • Los Angeles, California
    • +34 more
    Jun 5, 2012

    Healthy Trial in Richmond (Nilotinib)

    Completed
    • Healthy
    • Nilotinib
    • Richmond, Virginia
      (unnamed)
    Mar 7, 2012

    Gastrointestinal Stromal Tumors Trial (retaspimycin HCl (IPI-504), , Best supportive care)

    Terminated
    • Gastrointestinal Stromal Tumors
    • retaspimycin hydrochloride (IPI-504)
    • +2 more
    • (no location specified)
    Dec 7, 2012

    Chronic Myelogenous Leukemia, Short Stature Trial in Chandigarh (Growth Hormone)

    Unknown status
    • Chronic Myelogenous Leukemia
    • Short Stature
    • Growth Hormone
    • Chandigarh, UT, India
      Postgraduate Institute of Medical Education and Research
    Jul 12, 2013

    Collaborative Seamless Care in Oncology : Measure and Reinforce

    Unknown status
    • Cancer
      • Lausanne, Vaud, Switzerland
        Policlinique Médicale Universitaire and Centre pluridisciplinair
      Jul 16, 2012

      Myelogenous Leukemia Trial in Worldwide (Imatinib, Nilotinib (AMN107))

      Terminated
      Has Results
      • Myelogenous Leukemia
      • Tucson, Arizona
      • +79 more
      Nov 4, 2011

      Chronic Myelogenous Leukemia Trial in Canada (nilotinib)

      No longer available
      • Chronic Myelogenous Leukemia
      • nilotinib
      • Calgary, Alberta, Canada
      • +17 more
      Jul 12, 2011

      Gastrointestinal Stromal Tumors Trial in Seoul (Sorafenib)

      Completed
      • Gastrointestinal Stromal Tumors
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jan 18, 2012

      Malignant Skin Melanoma T0, Stage III Melanoma, Stage IV Melanoma Trial in Paris (Nilotinib)

      Unknown status
      • Malignant Skin Melanoma T0
      • +3 more
      • Nilotinib
      • Paris, France
        Hôpital Saint-Louis
      Feb 7, 2011